Ribavirin and interferon combination for recurrent post-transplant hepatitis C: which benefit beyond 6 months?

被引：7

作者：

Bizollon, T ^{[1
]}

Trepo, C ^{[1
]}

机构：

[1] Hop Hotel Dieu, Hepatol Unit, F-69288 Lyon 02, France

来源：

JOURNAL OF HEPATOLOGY | 2002年 / 37卷 / 02期

关键词：

D O I：

10.1016/S0168-8278(02)00200-3

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：274 / 276

页数：3

共 22 条

[1] HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].

Berenguer, M ;

Ferrell, L ;

Watson, J ;

Prieto, M ;

Kim, M ;

Rayón, M ;

Córdoba, J ;

Herola, A ;

Ascher, N ;

Mir, J ;

Berenguer, J ;

Wright, TL .

JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684

[2] Hepatitis C virus recurrence after liver transplantation [J].

Bizollon, T ;

Ducerf, C ;

Trepo, C ;

Mutimer, D .

GUT, 1999, 44 (04) :575-578

[3] Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation [J].

Bizollon, T ;

Palazzo, U ;

Ducerf, C ;

Chevallier, M ;

Elliott, M ;

Baulieux, J ;

Pouyet, M ;

Trepo, C .

HEPATOLOGY, 1997, 26 (02) :500-504

[4]

BIZOLLON T, 2002, IN PRESS GUT

[5] Long-term outcome of hepatitis C infection after liver transplantation [J].

Cane, EJ ;

Portmann, BC ;

Naoumov, NV ;

Smith, HM ;

Underhill, JA ;

Donaldson, PT ;

Maertens, G ;

Williams, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :815-820

[6] A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation [J].

Cattral, MS ;

Krajden, M ;

Wanless, IR ;

Rezig, M ;

Cameron, R ;

Greig, PD ;

Chung, SW ;

Levy, GA .

TRANSPLANTATION, 1996, 61 (10) :1483-1488

[7] Daily interferon therapy for hepatitis C virus infection in liver transplant recipients [J].

Cotler, SJ ;

Ganger, DR ;

Kaur, S ;

Rosenblate, H ;

Jakate, S ;

Sullivan, DG ;

Ng, KW ;

Gretch, DR ;

Jensen, DM .

TRANSPLANTATION, 2001, 71 (02) :261-266

[8] European collaborative study on factors influencing outcome after liver transplantation for hepatitis C [J].

Féray, C ;

Caccamo, L ;

Alexander, GJM ;

Ducot, B ;

Gugenheim, J ;

Casanovas, T ;

Loinaz, C ;

Gigou, M ;

Burra, P ;

Barkholt, L ;

Esteban, R ;

Bizollon, T ;

Lerut, J ;

Minello-Franza, A ;

Bernard, PH ;

Nachbaur, G ;

Botta-Fridlund, D ;

Bismuth, H ;

Schalm, SW ;

Samuel, D .

GASTROENTEROLOGY, 1999, 117 (03) :619-625

[9] AN OPEN TRIAL OF INTERFERON-ALFA RECOMBINANT FOR HEPATITIS-C AFTER LIVER-TRANSPLANTATION - ANTIVIRAL EFFECTS AND RISK OF REJECTION [J].

FERAY, C ;

SAMUEL, D ;

GIGOU, M ;

PARADIS, V ;

DAVID, MF ;

LEMONNIER, C ;

REYNES, M ;

BISMUTH, H .

HEPATOLOGY, 1995, 22 (04) :1084-1089

[10] The association between hepatitis C infection and survival after orthotopic liver transplantation [J].

Forman, LM ;

Lewis, JD ;

Berlin, JA ;

Feldman, HI ;

Lucey, MR .

GASTROENTEROLOGY, 2002, 122 (04) :889-896

← 1 2 3 →